New Jersey S 1694: Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2016-02-29)

State: New Jersey · Session: 217 · Bill: S 1694

Subjects: DISEASE, PHARMACEUTIC

Sponsors: Bucco, Anthony R.

View New Jersey S 1694 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.